CTRI/2017/12/010963已完成1 期
Redefining the role of metformin in non-hormonal acne: Asingle-blind randomized placebo controlled interventionalstudy comparing the efficacy of oral metformin and topicalBPO vs. placebo and topical BPO; with initial 1 month ofdoxycycline, in the treatment of moderate-severe facialacne. - ACME
Gauhati medical college0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •moderate or severe acne vulgaris as defined by the Investigatorâ??s Global Assessment (IGA; score of 3 or
排除标准
- •Patients with any clinical evidence of hormonal
- •dysfunction, metabolic syndrome, insulin resistance, hypertension, diabetes mellitus, and
- •PCOS will be excluded by appropriate testing methods.
- •Patients with acne conglobata, acne
- •fulminans or other dermatological pathologies over face which could interfere with treatment or evaluation to be excluded.
- •Patients on isotretinoin excluded and for any other medication(topical/oral) a period of 4 weeks abstinence
研究者
相似试验
进行中（未招募）
不适用
The Effect of Metformin, an insulin-sensitizing drug, on Breast Cancer Primary Prevention: The Plotina Breast Cancer Prevention Randomized, Placebo Controlled Trial - PLOTINABreast cancer chemopreventionEUCTR2009-009921-28-ITISTITUTI FISIOTERAPICI OSPITALIERI
已完成
不适用
Elucidation of a novel mechanism of metformin action through the gastrointestinal tractJPRN-UMIN000039517Kobe University
已完成
2 期
The effect of metformin in different phenotypes of poly cystic ovary syndrome according to Rotterdam criteria criteriapoly cystic ovary syndrome.PCOD ( poly cystic ovary syndrome)IRCT201103146063N1Tehran University of Medical Science and Health Service290
进行中（未招募）
不适用
The effect of metformin co-treatment in hormone-replacement frozen embryo replacement cycles in women with polycystic ovary syndrome. - Metformin in frozen embryo replacement cycles in women with PCOSPolycystic Ovary SyndromeEUCTR2009-017245-64-GBeeds Teaching Hospitals NHS Trust140
已完成
2 期
Gastrointestinal mechanisms underlying glucose lowering by metformin in type 2 diabetesType 2 diabetes mellitusMetabolic and Endocrine - DiabetesACTRN12617000243314niversity of Adelaide10